Company intelligence / Profile preview
Thendor Therapeutics
Huntington Beach, California, United Statesthendortx.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Thendor Therapeutics develops anti-fibrotic therapies based on peptides derived from collagen XVIII. Their lead candidate has shown efficacy in preclinical models of lung fibrosis, including scleroderma-associated pulmonary fibrosis. The company has received NIH funding to advance this research but has not yet reported clinical trial results[2][3][9].
- Therapeutic areas
- RheumatologyPulmonologyOther
- Modalities
- PeptidesSmall molecule
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Medical University of South Carolina
Beyond the preview
Go deeper on Thendor Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Thendor Therapeutics.